Skip to search formSkip to main contentSkip to account menu

forodesine hydrochloride

The hydrochloride salt of the synthetic high-affinity transition-state analogue forodesine. Forodesine binds preferentially to and inhibits purine… 
National Institutes of Health

Related topics

Related topics

2 relations
BCX1777immucillin H

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Gateways to clinical trials.
(-)-Gossypol; Alemtuzumab, Amlodipine, Anakinra, Azacitidine; Bazedoxifene acetate, Belinostat, Bevacizumab, BI-201335, BI-2536… 
2008
2008
Gateways to clinical trials.
(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC… 
2006
2006
Preclinical and early clinical study of forodesine hydrochloride (FH) in chronic lymphocytic leukemia (CLL).
5657 Mammalian purine nucleoside phosphorylase (PNP) deficiency in humans produces a relatively selective depletion of T cells… 
2005
2005
Development of Forodesine Hydrochloride (FH), an Inhibitor of Purine Nucleoside Phosphorylase, for Patients with Chronic Lymphocytic Leukemia (CLL).
Mammalian purine nucleoside phosphorylase (PNP) catalyzes the cleavage of inosine, deoxyinosine, guanosine, and deoxyguanosine… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials reported in current literature and congresses. The data… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)